Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary

Marianna Ofner-Agostini1, Monali Varia, Lynn Johnston

  • 1Nosocomial and Occupational Infections Section, Public Health Agency of Canada, Ottawa, Ontario, Canada. m.ofner@utoronto.ca

Insights

Canadian hospitals employ robust screening and infection control for antimicrobial-resistant organisms (AROs) like MRSA and VRE, contributing to low infection rates. Further research is needed to refine best practices.

Area of Science:

  • Healthcare epidemiology
  • Infectious disease control
  • Public health surveillance

Background:

  • Antimicrobial-resistant organisms (AROs) pose a significant threat to healthcare settings globally.
  • Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and extended-spectrum beta-lactamase (ESBL)-producing organisms are key AROs of concern.
  • Understanding current infection control and antimicrobial restriction policies is crucial for preventing ARO transmission.

Purpose of the Study:

  • To assess infection control and antimicrobial restriction policies and practices in Canadian teaching hospitals.
  • To examine the prevention strategies for MRSA, VRE, and ESBL/AmpC.
  • To correlate policies with observed rates of AROs in Canadian healthcare facilities.

Main Methods:

  • A survey was conducted in Canadian teaching hospitals as part of the Canadian Nosocomial Infection Surveillance Program in 2003.
  • Twenty-eight out of 29 hospitals returned questionnaires regarding their ARO policies and practices.
  • Data collected included screening protocols, prevalence surveys, isolation precautions, decolonization attempts, and antimicrobial prescribing restrictions.

Main Results:

  • High rates of admission screening for MRSA (96.4%) and VRE (89.3%) were reported, contrasting with low screening for ESBL/AmpC (1 site).
  • Canada reported low rates of MRSA, VRE, and ESBL, potentially linked to stringent screening and infection control measures.
  • Barrier precautions varied by ARO and setting; most facilities used gowns and gloves for MRSA/VRE, but less consistently for ESBL. Antimicrobial prescribing restriction policies were reported by 75.0% of facilities.

Conclusions:

  • Stringent admission screening and infection control policies are likely contributing factors to the low prevalence of MRSA, VRE, and ESBL in Canadian teaching hospitals.
  • Variations in barrier precautions and limited screening for ESBL/AmpC highlight areas for potential improvement.
  • Further research correlating specific hospital policies with ARO infection rates is recommended to refine best practice guidelines.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...